# Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

> clinical trial · VERIFIED · 2026-08-04

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Fallopian Tube Mucinous Adenocarcinoma

- Company: National Cancer Institute (NCI)
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04739800

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.